Vapotherm bags $24 mln

Vapotherm has raised $24 million in financing. Gilde Healthcare Partners led the round with participation from investors that included Adage Capital Management, 3×5 Special Opportunity Fund, Morgenthaler Ventures, QuestMark Partners and Cross Creek Capital. Based in Exeter, NH, Vapotherm is a maker of advanced respiratory care devices.


EXETER, N.H., April 3, 2014 /PRNewswire/ — On March 21, 2014, Vapotherm closed a $24MM financing round. Gilde Healthcare Partners, L.P., led the financing round, which also included new investor Adage Capital Management, L.P. and existing investors 3×5 Special Opportunity Fund, Morgenthaler Ventures, Kaiser Permanente, Integral Capital Partners, QuestMark Partners and Cross Creek Capital.
“We are excited by the Vapotherm opportunity and delighted to join the investor group,” said Geoff Pardo, General Partner of Gilde Healthcare Partners, and new member of the Board of Directors. “Vapotherm’s proprietary technology has proven to generate superior patient outcomes and lower the cost of care for providers. We look forward to the company growing and improving healthcare for patients world wide.”
“We are delighted to have Gilde and Adage join our existing investors. They both have strong track records in supporting growing medical device companies and we appreciate their confidence in our team and our products,” said Joe Army, President & CEO.
Vapotherm, Inc. is a privately held manufacturer of advanced respiratory care devices based in Exeter, New Hampshire. The company develops innovative, comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 600,000 patients have been treated with Vapotherm high flow therapy. For more information, visit

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.